Maxwell Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.55 M
- Company Age 11 Year, 21 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.99 M
- Revenue Growth 82.58%
- Profit Growth 12.21%
- Ebitda 76.66%
- Net Worth 83.14%
- Total Assets 58.69%
About Maxwell Formulations
Maxwell Formulations Private Limited (MFPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 February 2014 and has a history of 11 years. Its registered office is in Nellore, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.55 M.
The company currently has active open charges totaling ₹4.99 M.
Alapati Swathi and Alapati Reddy serve as directors at the Company.
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U15510AP2014PTC092719
- Company No.
092719
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Maxwell Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alapati Swathi  | Director | 03-Feb-2014 | Current |
| Alapati Reddy | Director | 03-Feb-2014 | Current |
Financial Performance of Maxwell Formulations.
Maxwell Formulations Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 82.58% increase. The company also saw a substantial improvement in profitability, with a 12.21% increase in profit. The company's net worth Soared by an impressive increase of 83.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxwell Formulations?
In 2017, Maxwell Formulations had a promoter holding of 28.26% and a public holding of 71.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.50 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2017 | State Bank Of India | ₹4.99 M | Open |
How Many Employees Work at Maxwell Formulations?
Unlock and access historical data on people associated with Maxwell Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxwell Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxwell Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.